<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(1)</volume><submitter>Yang Y</submitter><pubmed_abstract>As a chronic disorder, insomnia affects approximately 10% of the population at some time during their lives, and its treatment is often challenging. Since the antagonists of the H₁ receptor, a protein prevalent in human central nervous system, have been proven as effective therapeutic agents for treating insomnia, the H₁ receptor is quite possibly a promising target for developing potent anti-insomnia drugs. For the purpose of understanding the structural actors affecting the antagonism potency, presently a theoretical research of molecular interactions between 129 molecules and the H₁ receptor is performed through three-dimensional quantitative structure-activity relationship (3D-QSAR) techniques. The ligand-based comparative molecular similarity indices analysis (CoMSIA) model (Q² = 0.52</pubmed_abstract><journal>International journal of molecular sciences</journal><pagination>E129</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4730370</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Computational Analysis of Structure-Based Interactions for Novel H₁-Antihistamines.</pubmed_title><pmcid>PMC4730370</pmcid><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Pan Y</pubmed_authors><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Lin F</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Wang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Computational Analysis of Structure-Based Interactions for Novel H₁-Antihistamines.</name><description>As a chronic disorder, insomnia affects approximately 10% of the population at some time during their lives, and its treatment is often challenging. Since the antagonists of the H₁ receptor, a protein prevalent in human central nervous system, have been proven as effective therapeutic agents for treating insomnia, the H₁ receptor is quite possibly a promising target for developing potent anti-insomnia drugs. For the purpose of understanding the structural actors affecting the antagonism potency, presently a theoretical research of molecular interactions between 129 molecules and the H₁ receptor is performed through three-dimensional quantitative structure-activity relationship (3D-QSAR) techniques. The ligand-based comparative molecular similarity indices analysis (CoMSIA) model (Q² = 0.52</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jan</publication><modification>2026-05-05T08:09:45.148Z</modification><creation>2026-04-07T21:31:34.594Z</creation></dates><accession>S-EPMC4730370</accession><cross_references><pubmed>26797608</pubmed><doi>10.3390/ijms17010129</doi></cross_references></HashMap>